Navigation Links
Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
Date:5/5/2011

dosage strengths under the trade name Certican® for the prevention of organ rejection in heart and kidney transplant recipients.

Everolimus is exclusively licensed to Abbott and sublicensed to Boston Scientific for use in drug-eluting stents.

Not all indications are available in every country. As an investigational compound the safety and efficacy profile of everolimus has not yet been established in all countries in pancreatic or any other type of NET. Access to everolimus outside of the approved indications has been carefully controlled and monitored in clinical trials designed to better understand the potential benefits and risks of the compound. Because of the uncertainty of clinical trials, there is no guarantee that everolimus will become commercially available for pancreatic or any other type of NET, or additional indications anywhere else in the world.

Important Safety Information for Afinitor® (everolimus) tablets Patients should not take Afinitor if they are allergic to Afinitor or to any of its ingredients. Patients should tell their healthcare provider before taking Afinitor if they are allergic to sirolimus (Rapamune®#) or temsirolimus (Torisel®#).

Afinitor can cause serious side effects including lung or breathing problems, infections and kidney failure, which can lead to death. If patients experience these serious side effects, they may need to stop taking Afinitor for a while or use a lower dose. Patients should tell their healthcare provider right away if they have any of these symptoms: new or worsening cough, shortness of breath, chest pain, difficulty breathing or wheezing.

Afinitor may make patients more likely to develop an infection, such as pneumonia, or a bacterial, fungal or viral infection. Viral infections may include reactivation of hepatitis B in people who have had hepatitis B in the past. In some people these infections may be severe, and can even l
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
2. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
3. Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications
4. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
5. Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients
6. Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients
7. Final Approval of Novartis Gender Discrimination Settlement Slated for November 19
8. Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
9. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
10. Novartis to Expand Global Research Headquarters in Cambridge, MA
11. VIDEO From thenewsmarket.com and Novartis: Phase III Data Show That Novartis Meningococcal Vaccine Menveo® Demonstrated Robust Immunogenicity in Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... The Indiana Medical Device Manufacturers Council and ... Sciences Policy Forum to state legislators. The new policy ... Diagnostics in Indianapolis and featured ... Ellspermann and State Sen. Brandt Hershman . ... new Learning & Development Center, which is under construction ...
(Date:8/31/2015)... , Aug. 31, 2015  DICOM Grid,  ... today that it was recognized as a semifinalist ... software.  The awards are sponsored by ... related professionals in the medical imaging industry.  Since ... radiology professionals to acknowledge the contributions of their ...
(Date:8/31/2015)... TWINSBURG, Ohio , Aug. 31, 2015 /PRNewswire/ ... and applications, has acquired MACTek Corporation, a leading ... part of Pepperl+Fuchs, strategy to further extend its ... the WirelessHART market.    "We are ... to our existing portfolio," said Jim Bolin ...
Breaking Medicine Technology:Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 3DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2
... Tenn. , May 20 /PRNewswire-FirstCall / -- Cumberland Pharmaceuticals Inc. ... acute care and gastroenterology markets, today announced that Chief Commercial Officer ... Global Life Sciences Conference in New York at 11:30 ... , , , ...
... , May 20 LightLab Imaging, Inc. announced today that ... leading interventional cardiologist and Director of the Interventional Cardiovascular Center at University ... available to hospitals in the United States – Optical Coherence ... Dr. Costa ...
Cached Medicine Technology:Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010 2LightLab's C7-XR FD-OCT Intravascular Imaging System Featured on Good Morning America 2LightLab's C7-XR FD-OCT Intravascular Imaging System Featured on Good Morning America 3
(Date:8/31/2015)... ... , ... The Bay Pines VA Healthcare System (VAHCS) remains focused ... more doctors and nurses and expanding existing facilities and services. Spine surgery will ... Anthony Jabre was selected to lead and grow the Bay Pines VAHCS’s new spine ...
(Date:8/31/2015)... (PRWEB) , ... September 01, 2015 , ... ... “ Treatments for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy ... medical breakthrough. Traumatic brain injury has been largely untreatable - with mostly palliative ...
(Date:8/31/2015)... ... 2015 , ... Since 1946, the doctors and staff at Clifton Dental Associates ... patient arrives at the office, the staff will make them feel welcome and comfortable. ... to create a complete dental treatment plan that is unique to each smile! ...
(Date:8/31/2015)... ... ... the FCPX LUT Soft pack from Pixel Film Studios, editors can quickly and easily add ... formula for modifying an image. The LUT changes every pixel's color to the corresponding color ... LUT Soft requires Final Cut Pro X 10.2 or newer. , By manipulating each ...
(Date:8/31/2015)... ... 31, 2015 , ... According to an article published August 3rd ... adolescents who underwent bariatric surgery “felt significantly better two years after surgery.” The article ... in the study felt that their “mental health had been normalized” at the point ...
Breaking Medicine News(10 mins):Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Dentists Presents, Clifton Dental Associates! 2Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3
... has negatively affected the treatment received by children and adolescents ... The meeting was hosted in association with the European Society ... hurdles faced by patients and those who care for them ... The Directive (2001/20/EC) has been one of the most ...
... 2012) The Scott & White Heart & Vascular Institute ... of Approval as a hospital performing Ventricular Assist Device ... permanent support for end stage heart failure by means ... the program demonstrated compliance with The Joint Commission,s national ...
... Gordon HealthDay Reporter , TUESDAY, Feb. 14 ... doesn,t speed recovery, new research shows. "We did ... diagnosis of acute sinusitis, and found no benefit from ... of acute sinusitis," said study author Dr. Jane Garbutt, ...
... , TUESDAY, Feb. 14 (HealthDay News) -- People who drank ... to 5 pounds over half a year, according to new ... divided into three groups: those who switched to water from ... those who weren,t advised to change beverages but were given ...
... , Blood tests have been a mainstay of diagnostic ... of information concerning health and disease. Nevertheless, blood derived ... fully mined for its vital health information, according to ... Institute. In a new study appearing in the ...
... in the field of Physical Anthropology. She not only ... Czech Republic, but she is also the Chair of ... the Department of Genetics, Physical Anthropology and Animal Physiology ... carried out numerous pieces of work into nutritional habits, ...
Cached Medicine News:Health News:Calls for policy changes as lives put at risk by bureaucracy 2Health News:Calls for policy changes as lives put at risk by bureaucracy 3Health News:Antibiotics Don't Help Most Sinus Infections, Study Finds 2Health News:Antibiotics Don't Help Most Sinus Infections, Study Finds 3Health News:Switching to Water, Diet Drinks Linked to Modest Weight Loss 2Health News:Following a trail of blood: A new diagnostic tool comes of age 2Health News:Following a trail of blood: A new diagnostic tool comes of age 3Health News:Analyzing the causes of obesity in the Romani ethnic group 2Health News:Analyzing the causes of obesity in the Romani ethnic group 3
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
... X-Drape combines full 0.25 mm pb ... sterile drape material that can be ... between the clinician and the source ... clinician must be in very close ...
... The first mobile clinical assistant ... A convergence of technologies in the ... you normally do during your,shift such ... and take pictures using one single ...
Patent Pending lateral flow assay platform that contributes to increased sensitivty...
Medicine Products: